Topic: physician payments
Big Pharma doled out $3 billion to doctors and teaching hospitals in 2018 despite greater scrutiny on drugmakers' financial ties to providers.
A new study suggests that the consistency of payments from drugmakers to doctors matters the most when it comes to swaying prescribing habits.
The U.S. Senate has released a report on Insys that provides an insider’s view of a company leaning on physicians to help drive sales.
Under a bipartisan opioid bill finalized by Congress, drugmakers will have to disclose payments made to nurses and physician assistants as well.
CEO Pascal Soriot says his company will disclose doctor payments in an additional 11 countries by 2019, aiming to unveil all of them after that.
Doctors who got free meals, speaking fees and other payments from drugmakers also prescribed more opioids, a new analysis found.
Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.
Transparency hasn't made much of a difference when it comes to drug and device makers' payments to doctors, which amounted to $2.6 billion last year.
In Germany, a nonprofit is trying disclosure based on the honor system.
California lawmakers are weighing a bill that would cut off most drugmaker payments to physicians, including speaking fees for that staple of pharma marketing, the slideshow over dinner.